NUCLEAR DELIVERY PLATFORM Trademark

Trademark Overview


On Tuesday, December 17, 2019, a trademark application was filed for NUCLEAR DELIVERY PLATFORM with the United States Patent and Trademark Office. The USPTO has given the NUCLEAR DELIVERY PLATFORM trademark a serial number of 88730049. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 6, 2022. This trademark is owned by Angiex, Inc.. The NUCLEAR DELIVERY PLATFORM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine
nuclear delivery platform

General Information


Serial Number88730049
Word MarkNUCLEAR DELIVERY PLATFORM
Filing DateTuesday, December 17, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, April 6, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 20, 2019
Primary Code042
First Use Anywhere DateTuesday, December 31, 2019
First Use In Commerce DateSaturday, February 29, 2020

Trademark Owner History


Party NameAngiex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Thursday, April 7, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, April 6, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 1, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2021NON-FINAL ACTION E-MAILED
Wednesday, September 1, 2021NON-FINAL ACTION WRITTEN
Tuesday, August 31, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sunday, August 29, 2021USE AMENDMENT ACCEPTED
Friday, August 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 6, 2021AMENDMENT TO USE PROCESSING COMPLETE
Friday, August 6, 2021USE AMENDMENT FILED
Friday, August 6, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, August 5, 2021TEAS AMENDMENT OF USE RECEIVED
Wednesday, February 10, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 10, 2021FINAL REFUSAL E-MAILED
Wednesday, February 10, 2021FINAL REFUSAL WRITTEN
Saturday, January 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, January 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 23, 2021ASSIGNED TO LIE
Tuesday, October 13, 2020NOTICE OF REVIVAL - E-MAILED
Monday, October 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 12, 2020PETITION TO REVIVE-GRANTED
Monday, October 12, 2020TEAS PETITION TO REVIVE RECEIVED
Thursday, October 1, 2020ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, October 1, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, March 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020ASSIGNED TO EXAMINER
Friday, December 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 20, 2019NEW APPLICATION ENTERED